Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma. [electronic resource]
Producer: 19981117Description: 1109-13 p. digitalISSN:- 0140-6736
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Asthma -- drug therapy
- CD4 Antigens -- immunology
- CD4-Positive T-Lymphocytes -- drug effects
- Chronic Disease
- Dose-Response Relationship, Drug
- Female
- Humans
- Infusions, Intravenous
- Lymphocyte Count -- drug effects
- Male
- Middle Aged
- Respiratory Function Tests
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.